Health Fixer is recalling all lots of five male enhancement dietary supplements (Male Ultra, Malextra, Electro Buzz, Ultra ...

Alpha Cognition Inc. (NASDAQ: ACOG) (the "Company" or "Alpha Cognition") today announced three upcoming presentations at the 2025 Alzheimer's Association International Conference (the "AAIC"), taking ...

And once she became a mom, her migraine attacks made it tough to spend time with her kids. “It would take me out of the game, ...

Total net revenue of $76.3 million from Q1 2025 driven by Ohtuvayre® net sales of $71.3 million (+95% vs Q4 2024) ~25,000 prescr ...

How one man, along with his care team, turned an all-consuming cancer diagnosis into a management strategy with inspiration ...

Total net revenue of $76.3 million from Q1 2025 driven by Ohtuvayre® net sales of $71.3 million (+95% vs Q4 2024) ~25,000 prescriptions filled in Q1 2025 Q1 2025 revenue exceeds operating expenses exc ...

Given the impact depression has on sleep, it’s no wonder a common symptom of MDD is exhaustion. When you’re dealing with ...

AbbVie today announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib), 15 mg, once daily, for the treatment of adults with giant cell arteritis (GCA).1 This comes ...

Rezdiffra™ (resmetirom) net sales of $137.3 million As of March 31, 2025, more than 17,000 patients on Rezdiffra Two-year compensated MASH cirrhosis (F4c) data from MAESTRO-NAFLD-1 trial selected as ...

TNX-1700 is in preclinical development for gastric and colorectal cancers ...